dan 2163 has been researched along with Cognition Disorders in 12 studies
Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Both amisulpride and olanzapine produce sustained improvement in certain measures of neuropsychological performance in patients with schizophrenia; a significant improvement in score on the AVLT was observed only with amisulpride." | 9.12 | Treatment with amisulpride and olanzapine improve neuropsychological function in schizophrenia. ( Balasubramaniam, K; Choudhary, PC; Joyce, E; Mortimer, AM; Saleem, PT, 2007) |
| "Both amisulpride and olanzapine produce sustained improvement in certain measures of neuropsychological performance in patients with schizophrenia; a significant improvement in score on the AVLT was observed only with amisulpride." | 5.12 | Treatment with amisulpride and olanzapine improve neuropsychological function in schizophrenia. ( Balasubramaniam, K; Choudhary, PC; Joyce, E; Mortimer, AM; Saleem, PT, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (50.00) | 29.6817 |
| 2010's | 5 (41.67) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Mohamed, AM | 1 |
| Habib, MZ | 1 |
| Ebeid, MA | 1 |
| Abdelraouf, SM | 1 |
| El Faramawy, Y | 1 |
| Aboul-Fotouh, S | 1 |
| Magdy, Y | 1 |
| Bak, N | 1 |
| Ebdrup, BH | 1 |
| Oranje, B | 1 |
| Fagerlund, B | 1 |
| Jensen, MH | 1 |
| Düring, SW | 1 |
| Nielsen, MØ | 1 |
| Glenthøj, BY | 1 |
| Hansen, LK | 1 |
| Nikiforuk, A | 1 |
| Popik, P | 1 |
| Crespo-Facorro, B | 1 |
| Rodríguez-Sánchez, JM | 1 |
| Pérez-Iglesias, R | 1 |
| Mata, I | 1 |
| Ayesa, R | 1 |
| Ramirez-Bonilla, M | 1 |
| Martínez-Garcia, O | 1 |
| Vázquez-Barquero, JL | 1 |
| Goldberg, TE | 1 |
| Gomar, JJ | 1 |
| Ahn, YM | 2 |
| Lee, KY | 1 |
| Kim, CE | 1 |
| Kim, JJ | 1 |
| Kang, DY | 1 |
| Jun, TY | 1 |
| Choi, JS | 1 |
| Chung, IW | 1 |
| Kim, SH | 2 |
| Hwang, SS | 2 |
| Kim, YS | 2 |
| Jung, DC | 1 |
| Koychev, I | 1 |
| McMullen, K | 1 |
| Lees, J | 1 |
| Dadhiwala, R | 1 |
| Grayson, L | 1 |
| Perry, C | 1 |
| Schmechtig, A | 1 |
| Walters, J | 1 |
| Craig, KJ | 1 |
| Dawson, GR | 1 |
| Dourish, CT | 1 |
| Ettinger, U | 1 |
| Wilkinson, L | 1 |
| Williams, S | 1 |
| Deakin, JF | 1 |
| Barkus, E | 1 |
| Galderisi, S | 1 |
| Mucci, A | 1 |
| Bitter, I | 1 |
| Libiger, J | 1 |
| Bucci, P | 1 |
| Fleischhacker, WW | 1 |
| Kahn, RS | 1 |
| Limosin, F | 1 |
| Mortimer, AM | 1 |
| Joyce, E | 1 |
| Balasubramaniam, K | 1 |
| Choudhary, PC | 1 |
| Saleem, PT | 1 |
| Darcourt, G | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effectiveness of the RemedRugby Program, a Program of Ecological Cognitive Remediation of Social Cognition Disorders in Schizophrenia[NCT03775564] | 60 participants (Actual) | Interventional | 2014-11-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for dan 2163 and Cognition Disorders
| Article | Year |
|---|---|
[The use of atypical antipsychotics in the long-term care of schizophrenia].
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Benzodiazepines; Clozapine; | 2006 |
6 trials available for dan 2163 and Cognition Disorders
| Article | Year |
|---|---|
Two subgroups of antipsychotic-naive, first-episode schizophrenia patients identified with a Gaussian mixture model on cognition and electrophysiology.
Topics: Adult; Algorithms; Amisulpride; Antipsychotic Agents; Cognition Disorders; Electroencephalography; E | 2017 |
Neurocognitive effectiveness of haloperidol, risperidone, and olanzapine in first-episode psychosis: a randomized, controlled 1-year follow-up comparison.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Brain; Clozapine; Cognition Disorders; Fe | 2009 |
Changes in neurocognitive function in patients with schizophrenia after starting or switching to amisulpride in comparison with the normal controls.
Topics: Adult; Amisulpride; Antipsychotic Agents; Cognition Disorders; Female; Follow-Up Studies; Humans; Ma | 2009 |
A validation of cognitive biomarkers for the early identification of cognitive enhancing agents in schizotypy: a three-center double-blind placebo-controlled study.
Topics: Adult; Amisulpride; Analysis of Variance; Biomarkers; Cognition Disorders; Double-Blind Method; Fema | 2012 |
Persistent negative symptoms in first episode patients with schizophrenia: results from the European First Episode Schizophrenia Trial.
Topics: Adolescent; Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Cognition Disorders; Dibenzot | 2013 |
Treatment with amisulpride and olanzapine improve neuropsychological function in schizophrenia.
Topics: Acute Disease; Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Cognition Disorders; Dose- | 2007 |
5 other studies available for dan 2163 and Cognition Disorders
| Article | Year |
|---|---|
Amisulpride alleviates chronic mild stress-induced cognitive deficits: Role of prefrontal cortex microglia and Wnt/β-catenin pathway.
Topics: Amisulpride; Animals; Attention; Behavior, Animal; beta Catenin; Cognition Disorders; Depression; En | 2020 |
Amisulpride promotes cognitive flexibility in rats: the role of 5-HT7 receptors.
Topics: Amisulpride; Animals; Antipsychotic Agents; Attention; Cognition Disorders; Disease Models, Animal; | 2013 |
Targeting cognition in schizophrenia research: from etiology to treatment.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Cognition; Cognition Disorders; Dibenzothiazepin | 2009 |
The effects of psychopathology on subjective experience of side effects of antipsychotics in patients with schizophrenia.
Topics: Adult; Amisulpride; Antipsychotic Agents; Anxiety; Benzodiazepines; Cognition Disorders; Depressive | 2010 |
Amisulpride: its role in the therapeutic management of the schizophrenic patient. Introduction.
Topics: Amisulpride; Antipsychotic Agents; Cognition Disorders; Humans; Schizophrenia; Sulpiride | 2000 |